Protalix Biotherapeutics Inc. buy marge
Start price
12.04.17
/
50%
€10.35
Target price
26.07.17
€20.00
Performance (%)
-40.29%
End price
26.07.17
€6.18
Summary
This prediction ended on 26.07.17 with a price of €6.18. The BUY prediction by marge for Protalix Biotherapeutics Inc. performed very badly with a performance of -40.29%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Protalix Biotherapeutics Inc. | 7.119% | 7.119% | 56.694% | -7.059% |
| iShares Core DAX® | 0,88 % | 1,05 % | 7,09 % | 54,45 % |
| iShares Nasdaq 100 | 0,75 % | 4,66 % | 41,85 % | 95,49 % |
| iShares Nikkei 225® | 5,52 % | 15,41 % | 73,76 % | 85,82 % |
| iShares S&P 500 | 0,24 % | 1,68 % | 27,53 % | 69,02 % |
Comments by marge for this prediction
In the thread Protalix Biotherapeutics Inc. diskutieren
marge stimmt der Buy-Einschätzung von datca zu
marge stimmt am 124.2017 der Buy-Einschätzung von datca mit dem Kursziel 2€ zu.Überschrift: Protalix for the Treatment of Cystic Fibrosis and Fabry Disease
(Vom Mitglied beendet)